| For: | Wu JY, Zhou Y, Zhang GM, Mu GF, Yi S, Yin N, Xie YP, Lin XC, Li HJ, Sun MS. Isolation and characterization of a new candidate human inactivated rotavirus vaccine strain from hospitalized children in Yunnan, China: 2010-2013. World J Clin Cases 2018; 6(11): 426-440 [PMID: 30294607 DOI: 10.12998/wjcc.v6.i11.426] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v6/i11/426.htm |
| Number | Citing Articles |
| 1 |
Farzane Behnezhad, Angila Ataei-Pirkooh, Atefeh Kachooei, Forough Golsaz-Shirazi, Arash Arashkia, Mahtab Mir-Hosseinian, Somayeh-Sadat Hosseini-Fakhr, Leila Mousavizadeh, Somayeh Jalilvand, Farzin Roohvand, Zabihollah Shoja. The rotavirus cVLPVP8∗ vaccine candidate induces cross-genotype/heterotypic neutralizing antibody responses against human rotavirus G9P[4]. Virology 2026; 621 doi: 10.1016/j.virol.2026.110957
|
| 2 |
Alexandre C. Linhares, Maria Cleonice A. Justino. Viral Infections of Humans. 2023; doi: 10.1007/978-1-4939-9544-8_59-2
|
| 3 |
Jin-Yuan Wu, Wei Zhang, Jing Pu, Yan Liu, Li-Li Huang, Yan Zhou, Jia-Mei Gao, Jie-Bing Tan, Xin-Ling Liu, Jing Yang, Xiao-Chen Lin, Guang-Wei Feng, Na Yin, Rong Chen, Xiao-Qing Hu, Shan Yi, Jun Ye, Xiang-Jing Kuang, Yan Wang, Guang-Ming Zhang, Mao-Sheng Sun, Yan-Xia Wang, Zhong-Yu Hu, Jing-Si Yang, Hong-Jun Li. A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18–49 years to assess safety and preliminary observation of immunogenicity. Vaccine 2024; 42(19) doi: 10.1016/j.vaccine.2024.05.014
|
| 4 |
Yan Zhou, Xiaoqing Hu, Rong Chen, Jinyuan Wu, Xiaochen Lin, Chenxing Lu, Na Yin, Yaya Tang, Peng Shi, Zexin Song, Yongmei Zhao, Maosheng Sun, Hongjun Li. Impact of maternal and pre-existing antibodies on immunogenicity of inactivated rotavirus vaccines. Vaccine 2022; 40(28) doi: 10.1016/j.vaccine.2022.05.036
|
| 5 |
Yuxiao Wang, Jingxin Li, Pei Liu, Fengcai Zhu. The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review. Human Vaccines & Immunotherapeutics 2021; 17(3) doi: 10.1080/21645515.2020.1801071
|
| 6 |
Tayebeh Latifi, Somayeh Jalilvand, Forough Golsaz‐Shirazi, Arash Arashkia, Atefeh Kachooei, Atefeh Afchangi, Saman Zafarian, Farzin Roohvand, Zabihollah Shoja. Characterization and immunogenicity of a novel chimeric hepatitis B core-virus like particles (cVLPs) carrying rotavirus VP8*protein in mice model. Virology 2023; 588 doi: 10.1016/j.virol.2023.109903
|
| 7 |
Jin-Xia Wang, Li-Na Chen, Can-Jing Zhang, Hong-Lu Zhou, Yan-Hong Zhang, Xin-Jiang Zhang, Zhi-Yong Hao, Chao Qiu, Jing-Chen Ma, Yu-Liang Zhao, Weiming Zhong, Ming Tan, Xi Jiang, Song-Mei Wang, Xuan-Yi Wang. Genetic susceptibility to rotavirus infection in Chinese children: a population-based case–control study. Human Vaccines & Immunotherapeutics 2021; 17(6) doi: 10.1080/21645515.2020.1835121
|
| 8 |
Alexandre C. Linhares, Maria Cleonice A. Justino. Viral Infections of Humans. 2022; doi: 10.1007/978-1-4939-9544-8_59-1
|
| 9 |
Yan Zhou, Jinyuan Wu, Xiaoqing Hu, Rong Chen, Xiaochen Lin, Na Yin, Chenxing Lu, Jun Ye, Yongmei Zhao, Xiaopeng Song, Zexin Song, Jinlan Wang, Yan Li, Jinmei Li, Guangming Zhang, Maosheng Sun, Hongjun Li. Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms. Human Vaccines & Immunotherapeutics 2023; 19(1) doi: 10.1080/21645515.2023.2189598
|
| 10 |
Xiaochen Lin, Hongjun Li. Diverse processes in rotavirus vaccine development. Human Vaccines & Immunotherapeutics 2025; 21(1) doi: 10.1080/21645515.2025.2475609
|
| 11 |
Rachel M. Burke, Jacqueline E. Tate, Carl D. Kirkwood, A. Duncan Steele, Umesh D. Parashar. Current and new rotavirus vaccines. Current Opinion in Infectious Diseases 2019; 32(5) doi: 10.1097/QCO.0000000000000572
|
| 12 |
Ahmed H. Ghonaim, GuangYuan Yi, Mingkai Lei, Dongqi Xie, Hailong Ma, Zhengxin Yang, Usama Usama, Hao Wu, Yunbo Jiang, Wentao Li, Qigai He. Isolation, characterization and whole-genome analysis of G9 group a rotaviruses in China: Evidence for possible Porcine–Human interspecies transmission. Virology 2024; 597 doi: 10.1016/j.virol.2024.110129
|